NEW ANGIOTENSIN II RECEPTOR BLOCKER FIMASARTAN IN MILD-TO-MODERATE HYPERTENSION: POST-HOC ANALYSIS OF RESULTS OF REGISTRATION TRIAL IN RUSSIA

Arterial’naya Gipertenziya (Arterial Hypertension) ◽

10.18705/1607-419x-2018-24-1-110-119 ◽

2018 ◽

Vol 24 (1) ◽

pp. 110-119

Author(s):

N. E. Zvartau ◽

E. V. Verbitskaya ◽

T. L. Galankin ◽

A. O. Konradi ◽

N. Yu. Khozyainova ◽

...

Keyword(s):

Angiotensin Ii ◽

Moderate Hypertension ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Post Hoc Analysis ◽

Analysis Of Results ◽

Registration Trial ◽

Download Full-text

SP141THE DECREMENT OF HEMOGLOBIN CONCENTRATION WITH ANGIOTENSIN II RECEPTOR BLOCKER TREATMENT IS CORRELATED WITH THE REDUCTION OF ALBUMINURIA IN NON-DIABETIC HYPERTENSIVE PATIENTS: POST-HOC ANALYSIS OF ESPECIAL TRIAL

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfv189.14 ◽

2015 ◽

Keyword(s):

Angiotensin Ii ◽

Hemoglobin Concentration ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Post Hoc Analysis ◽

Download Full-text

The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial

PLoS ONE ◽

10.1371/journal.pone.0128632 ◽

2015 ◽

Vol 10 (6) ◽

pp. e0128632 ◽

Author(s):

Jung Nam An ◽

Jin Ho Hwang ◽

Jung Pyo Lee ◽

Ho Jun Chin ◽

Sejoong Kim ◽

...

Keyword(s):

Angiotensin Ii ◽

Hemoglobin Concentration ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Post Hoc Analysis ◽

Download Full-text

E142 The angiotensin-II receptor blocker candesartan cilexetil provides 24-hour blood pressure control with once-a-day administration in mild-to-moderate hypertension

American Journal of Hypertension ◽

10.1016/s0895-7061(97)91678-2 ◽

1998 ◽

Vol 11 (4) ◽

pp. 262A

Author(s):

C ZUSCHKE

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Blood Pressure Control ◽

Moderate Hypertension ◽

Candesartan Cilexetil ◽

Pressure Control ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor

Download Full-text

Association between serum 25‐hydroxyvitamin D and the effects of Angiotensin II receptor blocker on renal function among African Americans: A post hoc analysis of a randomized placebo‐controlled trial

Journal of Clinical Hypertension ◽

10.1111/jch.13997 ◽

2020 ◽

Vol 22 (10) ◽

pp. 1874-1883

Author(s):

Li Chen ◽

Haidong Zhu ◽

Gregory A. Harshfield ◽

Ying Huang ◽

Yanbin Dong

Keyword(s):

Renal Function ◽

Angiotensin Ii ◽

African Americans ◽

Controlled Trial ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Post Hoc Analysis ◽

Hydroxyvitamin D ◽

25 Hydroxyvitamin D ◽

Download Full-text

E046 The angiotensin-II receptor blocker candesartan cilexetil provides 24-hour blood pressure control with once-a-day administration in mild-to-moderate hypertension

American Journal of Hypertension ◽

10.1016/s0895-7061(97)91108-0 ◽

1998 ◽

Vol 11 (4) ◽

pp. 107A

Author(s):

C ZUCHSKE

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Blood Pressure Control ◽

Moderate Hypertension ◽

Candesartan Cilexetil ◽

Pressure Control ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor

Download Full-text

Left ventricular mass and mechanics in mild to moderate hypertension: effect of b-blocker versus angiotensin ii receptor blocker

American Journal of Hypertension ◽

10.1016/j.amjhyper.2004.03.444 ◽

2004 ◽

Vol 17 (5) ◽

pp. S169

Author(s):

A FOUNTOULAKI

Keyword(s):

Angiotensin Ii ◽

Left Ventricular Mass ◽

Moderate Hypertension ◽

Left Ventricular ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Ventricular Mass

Download Full-text

Effect of angiotensin-II receptor blocker candesartan alone or in combination with aldoster-one antagonist spironolactone on diastolic function in patients with chronic heart failure and relatively no

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(08)60438-5 ◽

2008 ◽

Vol 7 ◽

pp. 159-159

Author(s):

F AGEEV ◽

O SVIRIDA ◽

A OVCHINNIKOV

Keyword(s):

Heart Failure ◽

Angiotensin Ii ◽

Chronic Heart Failure ◽

Diastolic Function ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor

Download Full-text

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)

BMC Cardiovascular Disorders ◽

10.1186/1471-2261-6-39 ◽

2006 ◽

Vol 6 (1) ◽

Author(s):

Ryuzo Kawamori ◽

Hiroyuki Daida ◽

Yasushi Tanaka ◽

Katsumi Miyauchi ◽

Akira Kitagawa ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Evaluation Trial

Download Full-text

Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms

PLoS ONE ◽

10.1371/journal.pone.0049642 ◽

2012 ◽

Vol 7 (12) ◽

pp. e49642 ◽

Author(s):

Yasunori Iida ◽

Baohui Xu ◽

Geoffrey M. Schultz ◽

Vinca Chow ◽

Julie J. White ◽

...

Keyword(s):

Angiotensin Ii ◽

Abdominal Aortic Aneurysms ◽

Aortic Aneurysms ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Abdominal Aortic

Download Full-text

911 A Novel Use of Angiotensin II Receptor Blocker (ARB) Losartan to Inhibit AOM Induced Tumorigenesis and Neoangiogenesis in Experimental Colon Cancer

Gastroenterology ◽

10.1016/s0016-5085(15)30574-6 ◽

2015 ◽

Vol 148 (4) ◽

pp. S-172 ◽

Author(s):

Vesta Valuckaite ◽

Sarah Ruderman ◽

Anas Almoghrabi ◽

John Hart ◽

Almaz Abdyrakov ◽

...

Keyword(s):

Colon Cancer ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor

Download Full-text